These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8148221)

  • 21. Comparative pharmacokinetics of zidovudine and its toxic catabolite 3'-amino-3'-deoxythymidine in HIV-infected patients.
    Zhou XJ; Sommadossi JP
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):229-33. PubMed ID: 8835201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients.
    Rolinski B; Bogner JR; Sadri I; Wintergerst U; Goebel FD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):192-7. PubMed ID: 9257653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations.
    Stretcher BN; Pesce AJ; Murray JA; Hurtubise PE; Vine WH; Frame PT
    Ther Drug Monit; 1991 Jul; 13(4):325-31. PubMed ID: 1780965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).
    McCance-Katz EF; Rainey PM; Jatlow P; Friedland G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):435-43. PubMed ID: 9715839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells.
    Robbins BL; Rodman J; McDonald C; Srinivas RV; Flynn PM; Fridland A
    Antimicrob Agents Chemother; 1994 Jan; 38(1):115-21. PubMed ID: 7511360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.
    Gallicano KD; Sahai J; Shukla VK; Seguin I; Pakuts A; Kwok D; Foster BC; Cameron DW
    Br J Clin Pharmacol; 1999 Aug; 48(2):168-79. PubMed ID: 10417493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.
    Barry MG; Khoo SH; Veal GJ; Hoggard PG; Gibbons SE; Wilkins EG; Williams O; Breckenridge AM; Back DJ
    AIDS; 1996 Oct; 10(12):1361-7. PubMed ID: 8902065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
    Aweeka FT; Kang M; Yu JY; Lizak P; Alston B; Chung RT;
    HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?
    Fauchet F; Treluyer JM; Valade E; Benaboud S; Pannier E; Firtion G; Foissac F; Bouazza N; Urien S; Hirt D
    Br J Clin Pharmacol; 2014 Dec; 78(6):1387-96. PubMed ID: 25040510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.
    Stretcher BN; Pesce AJ; Frame PT; Stein DS
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1541-7. PubMed ID: 7979286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.
    Kroidl A; Ello F; Mgaya J; Lennemann T; Moh R; Maganga L; Eholie S; Pruvost A; Saathoff E; Girard PM; Zuhse R; von Massow F; Anglaret X; Hoelscher M; Danel C;
    AIDS; 2017 Feb; 31(4):501-509. PubMed ID: 27941394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.
    Slusher JT; Kuwahara SK; Hamzeh FM; Lewis LD; Kornhauser DM; Lietman PS
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2473-7. PubMed ID: 1489190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.
    Schwartz EL; Brechbühl AB; Kahl P; Miller MA; Selwyn PA; Friedland GH
    J Acquir Immune Defic Syndr (1988); 1992; 5(6):619-26. PubMed ID: 1588496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children.
    Capparelli EV; Englund JA; Connor JD; Spector SA; McKinney RE; Palumbo P; Baker CJ
    J Clin Pharmacol; 2003 Feb; 43(2):133-40. PubMed ID: 12616665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.
    Sahai J; Gallicano K; Garber G; Pakuts A; Cameron W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):54-60. PubMed ID: 7648285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of antineoplastic chemotherapy with zidovudine pharmacokinetics in patients with HIV-related neoplasms.
    Toffoli G; Errante D; Corona G; Vaccher E; Bertola A; Robieux I; Aita P; Sorio R; Tirelli U; Boiocchi M
    Chemotherapy; 1999; 45(6):418-28. PubMed ID: 10567772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
    Mirochnick M; Rodman JH; Robbins BL; Fridland A; Gandía J; Hitti J; Bardeguez A; Rathore MH; Gonzalez Garcia A; Cababasay M; Samson P; Mofenson L; Bryson YJ; Dorenbaum A
    HIV Med; 2007 Oct; 8(7):451-6. PubMed ID: 17760737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High exposure to zidovudine during the first 2 weeks of life and concentration-toxicity relationships.
    Hirt D; Warszawski J; Firtion G; Giraud C; Chappuy H; Lechenadec J; Benaboud S; Urien S; Blanche S; Tréluyer JM
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):555-62. PubMed ID: 23481669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of Zidovudine.
    Veal GJ; Back DJ
    Gen Pharmacol; 1995 Nov; 26(7):1469-75. PubMed ID: 8690233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of the kinetics of zidovudine in the pregnant baboon following oral administration.
    Garland M; Szeto HH; Daniel SS; Tropper PJ; Myers MM; Stark RI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):433-40. PubMed ID: 9859956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.